Drug intelligence / Profile preview

HUNS001-01

Development stage
Phase 2
Lead developer
Hokkaido University
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intracerebral
01

Overview

HUNS001-01 is an autologous bone marrow-derived mesenchymal stem cell (BMSC) therapy developed for the treatment of ischemic stroke. The cells are harvested from the patient's own bone marrow and cultured using allogeneic human platelet lysate as a growth medium, avoiding the use of fetal bovine serum. A distinguishing feature of HUNS001-01 is its labeling with superparamagnetic iron oxide (SPIO), which allows for non-invasive longitudinal monitoring of cell migration and engraftment using magnetic resonance imaging (MRI). The therapy is administered via stereotactic intracerebral transplantation into the peri-infarct area. It is intended to promote neurological recovery in patients with subacute or chronic stroke sequelae through paracrine signaling, neuroprotection, and the facilitation of neural circuit remodeling.

Other names
Autologous bone marrow stromal cellsSPIO-labeled autologous BMSCsRAINBOW cell product

Beyond the preview

Go deeper on HUNS001-01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HUNS001-01.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call